IntroductionThe addition of antagonists is mainly based on estrogen level and follicle size, while LH level has not received sufficient attention.In this study, LH Level on the antagonist administration day was used as the main research objective to explore its relationship with laboratory indicators and pregnancy outcomes.Methods and AnalysisWe enrolled 854 patients with normal ovarian function undergoing in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) between May 2021 to May 2022 at the Reproductive Center of Shandong University of Traditional Chinese Medicine.We used the quartile method to group LH levels on the antagonist administration day. There were four groups: Q1 (0.53IU/L≤LH ≤ 1.89IU/L); Q2 (1.89IU/L<LH ...
Abstract Backgroud To investigate the effect of Luteinizing hormone (LH) level changes on the outcom...
textabstractIn a randomized multicenter study, the efficacies of two different GnRH agonists w...
Objective: To investigate the effect of serum estradiol (E-2) levels on the day of human chorionic g...
Objective: To investigate whether circulating LH levels could be used as an indicator for the timing...
Background: The significance of suppressed LH levels in GnRH antagonist cycles for IVF outcome is cu...
Luteinizing hormone (LH) is essential for normal follicular development and oocyte maturation. In pa...
Background: Circulating levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and p...
Introduction Many patients demonstrate an insufficient endogenous luteinising hormone (LH) concentra...
Background: Because of the unexpected and often dramatic inhibition of luteinizing hormone (LH) secr...
Background: Luteinizing hormone (LH) is essential for normal follicular development and oocyte matur...
The objective of this prospective study was to assess the relationship of LH and oestradiol on day 7...
Background: Objective of current study was to assess the effect of GnRH antagonist on follicular dev...
Background: Gonadotropin-releasing hormone (GnRH) antagonist produces immediate suppression of gonad...
BACKGROUND: The purpose of the study was to assess ongoing pregnancy rates across groups of patients...
BACKGROUND: This randomized controlled trial was designed to evaluate whether a GnRH antagonist give...
Abstract Backgroud To investigate the effect of Luteinizing hormone (LH) level changes on the outcom...
textabstractIn a randomized multicenter study, the efficacies of two different GnRH agonists w...
Objective: To investigate the effect of serum estradiol (E-2) levels on the day of human chorionic g...
Objective: To investigate whether circulating LH levels could be used as an indicator for the timing...
Background: The significance of suppressed LH levels in GnRH antagonist cycles for IVF outcome is cu...
Luteinizing hormone (LH) is essential for normal follicular development and oocyte maturation. In pa...
Background: Circulating levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and p...
Introduction Many patients demonstrate an insufficient endogenous luteinising hormone (LH) concentra...
Background: Because of the unexpected and often dramatic inhibition of luteinizing hormone (LH) secr...
Background: Luteinizing hormone (LH) is essential for normal follicular development and oocyte matur...
The objective of this prospective study was to assess the relationship of LH and oestradiol on day 7...
Background: Objective of current study was to assess the effect of GnRH antagonist on follicular dev...
Background: Gonadotropin-releasing hormone (GnRH) antagonist produces immediate suppression of gonad...
BACKGROUND: The purpose of the study was to assess ongoing pregnancy rates across groups of patients...
BACKGROUND: This randomized controlled trial was designed to evaluate whether a GnRH antagonist give...
Abstract Backgroud To investigate the effect of Luteinizing hormone (LH) level changes on the outcom...
textabstractIn a randomized multicenter study, the efficacies of two different GnRH agonists w...
Objective: To investigate the effect of serum estradiol (E-2) levels on the day of human chorionic g...